Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Net Block

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Net Block History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Block ₹18,620 Cr₹19,004 Cr₹4,540 Cr₹4,245 Cr₹3,583 Cr

What is the latest Net Block ratio of MANKIND PHARMA ?

The latest Net Block ratio of MANKIND PHARMA is ₹18,620 Cr based on Mar2026 Consolidated results.
Year Net Block
Mar2026₹18,620 Cr
Mar2025₹19,004 Cr
Mar2024₹4,540 Cr
Mar2023₹4,245 Cr
Mar2022₹3,583 Cr

How is Net Block of MANKIND PHARMA Trending?

Years Net Block % Change
Mar2026 ₹18,620 Cr
-2.02
Mar2025 ₹19,004 Cr
318.61
Mar2024 ₹4,540 Cr
6.94
Mar2023 ₹4,245 Cr
18.49
Mar2022 ₹3,583 Cr -

Compare Net Block of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹99,078.7 Cr 0.5% -7.4% -7.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹469,310.0 Cr 0.5% -4% 15.7% Stock Analytics
DIVIS LABORATORIES ₹245,426.0 Cr 9.1% 18.2% 47.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,347.0 Cr 3.6% 3.4% 36.4% Stock Analytics
CIPLA ₹114,393.0 Cr -1.2% -3.3% -10.8% Stock Analytics
DR REDDYS LABORATORIES ₹97,240.2 Cr -1.4% 2.9% -8% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

0.5%

-7.4%

-7.3%

SENSEX

-0.5%

-1.3%

-5.4%


You may also like the below Video Courses